BRIEF-Hubei Biocause Pharma Says Premium Income At Insurance Unit Totalled At 5.3 Bln Yuan In Jan

Reuters · 02/05/2021 10:21
BRIEF-Hubei Biocause Pharma Says Premium Income At Insurance Unit Totalled At 5.3 Bln Yuan In Jan

- Hubei Biocause Pharmaceutical Co Ltd 000627.SZ:

  • SAYS PREMIUM INCOME AT ITS INSURANCE UNIT TOTALLED AT 5.3 BILLION YUAN ($819.10 million) IN JANUARY

Source text in Chinese: https://bit.ly/3aBq2UD

Further company coverage: 000627.SZ


($1 = 6.4705 Chinese yuan renminbi)


(Reporting by Hong Kong newsroom)

((meg.shen@thomsonreuters.com; 852-39525805;))